Home/Filings/4/0001735276-23-000038
4//SEC Filing

Franchini Indrani Lall 4

Accession 0001735276-23-000038

CIK 0001178670other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 4:29 PM ET

Size

4.8 KB

Accession

0001735276-23-000038

Insider Transaction Report

Form 4
Period: 2023-04-06
Franchini Indrani Lall
EVP, CLO & Secretary
Transactions
  • Sale

    Common Stock

    2023-04-06$210.00/sh3,500$735,0000 total
Footnotes (1)
  • [F1]All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

Entity typeother

Related Parties

1
  • filerCIK 0001708764

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:29 PM ET
Size
4.8 KB